Pharis Mohideen - 29 Jul 2022 Form 4 Insider Report for DBV Technologies S.A. (DBVT)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Issuer symbol
DBVT
Transactions as of
29 Jul 2022
Transactions value $
-$6,821
Form type
4
Filing time
14 Aug 2023, 17:32:21 UTC
Previous filing
24 Nov 2021
Next filing
22 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DBVT Ordinary Shares Award $0 +10K +41.32% $0.00 34.2K 29 Jul 2022 Direct F1, F2
transaction DBVT Ordinary Shares Award $0 +17.5K +51.17% $0.00 51.7K 21 Nov 2022 Direct F1, F3
transaction DBVT Ordinary Shares Sale -$5.16K -1.79K -3.47% $2.88 49.9K 24 Nov 2022 Direct F1, F4, F5
transaction DBVT Ordinary Shares Sale -$1.66K -469 -0.94% $3.54 49.4K 24 May 2023 Direct F1, F4, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBVT Employee Stock Option (right to buy) Award $0 +100K $0.00 100K 29 Jul 2022 Ordinary Shares 100K $4.83 Direct F7, F8
transaction DBVT Employee Stock Option (right to buy) Award $0 +115K $0.00 115K 21 Nov 2022 Ordinary Shares 115K $3.07 Direct F9, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The ordinary shares may be represented by American Depositary Shares, each of which currently represents one-half of one ordinary share.
F2 Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
F3 Represents the Issuer's ordinary shares underlying a restricted stock unit RSU award. Each RSU represents a contingent right to receive one ordinary share. 25% of the shares underlying the RSU vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject in each case to the Reporting Person continuing to provide service through each such date.
F4 Shares sold to satisfy withholding tax obligations upon the the vesting of RSUs.
F5 This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0409 to EURO 1.00 as of November 24, 2022.
F6 This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0746 to EURO 1.00 as of May 24, 2023.
F7 This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0226 to EURO 1.00 as of July 29, 2022.
F8 25% of the shares subject to the option vest on July 29, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
F9 This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.0242 to EURO 1.00 as of November 21, 2022.
F10 25% of the shares subject to the option vest on November 21, 2023, with the remaining shares vesting in six equal semi-annual installments thereafter, subject to the Reporting Person continuing to provide service through each such date.